The shift of therapeutic strategy for prolactinomas: surgery as the first-line option
Crossref DOI link: https://doi.org/10.1038/s41574-024-00953-5
Published Online: 2024-01-22
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Zhe Bao http://orcid.org/0000-0002-1611-8228
Text and Data Mining valid from 2024-01-22
Version of Record valid from 2024-01-22
Article History
First Online: 22 January 2024
Competing interests
: The author declares no competing interests.